25 XP   0   0   10

Ningbo Menovo Pharm Co Ltd
Buy, Hold or Sell?

Let's analyse Ningbo Menovo Pharm Co Ltd together

PenkeI guess you are interested in Ningbo Menovo Pharm Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ningbo Menovo Pharm Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ningbo Menovo Pharm Co Ltd

I send you an email if I find something interesting about Ningbo Menovo Pharm Co Ltd.

Quick analysis of Ningbo Menovo Pharm Co Ltd (30 sec.)










What can you expect buying and holding a share of Ningbo Menovo Pharm Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.13
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥10.18
Expected worth in 1 year
¥13.83
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥4.58
Return On Investment
37.9%

For what price can you sell your share?

Current Price per Share
¥12.10
Expected price per share
¥9.96 - ¥16.18
How sure are you?
50%

1. Valuation of Ningbo Menovo Pharm Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥12.10

Intrinsic Value Per Share

¥-17.63 - ¥-8.83

Total Value Per Share

¥-7.45 - ¥1.36

2. Growth of Ningbo Menovo Pharm Co Ltd (5 min.)




Is Ningbo Menovo Pharm Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$300.3m$273.4m$26.9m9.0%

How much money is Ningbo Menovo Pharm Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$46.8m$19.6m$27.1m57.9%
Net Profit Margin23.2%11.3%--

How much money comes from the company's main activities?

3. Financial Health of Ningbo Menovo Pharm Co Ltd (5 min.)




What can you expect buying and holding a share of Ningbo Menovo Pharm Co Ltd? (5 min.)

Welcome investor! Ningbo Menovo Pharm Co Ltd's management wants to use your money to grow the business. In return you get a share of Ningbo Menovo Pharm Co Ltd.

What can you expect buying and holding a share of Ningbo Menovo Pharm Co Ltd?

First you should know what it really means to hold a share of Ningbo Menovo Pharm Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Ningbo Menovo Pharm Co Ltd is ¥12.10. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ningbo Menovo Pharm Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ningbo Menovo Pharm Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥10.18. Based on the TTM, the Book Value Change Per Share is ¥0.91 per quarter. Based on the YOY, the Book Value Change Per Share is ¥1.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.23 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ningbo Menovo Pharm Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.221.8%0.221.8%0.090.8%0.110.9%0.070.6%
Usd Book Value Change Per Share0.131.0%0.131.0%0.141.2%0.131.1%0.110.9%
Usd Dividend Per Share0.030.3%0.030.3%0.010.1%0.030.2%0.020.1%
Usd Total Gains Per Share0.161.3%0.161.3%0.151.2%0.161.3%0.131.1%
Usd Price Per Share3.56-3.56-4.91-3.95-2.34-
Price to Earnings Ratio16.22-16.22-53.16-39.74-32.47-
Price-to-Total Gains Ratio22.47-22.47-32.96-25.47-23.37-
Price to Book Ratio2.53-2.53-3.83-3.47-2.22-
Price-to-Total Gains Ratio22.47-22.47-32.96-25.47-23.37-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.67222
Number of shares598
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.03
Usd Book Value Change Per Share0.130.13
Usd Total Gains Per Share0.160.16
Gains per Quarter (598 shares)94.7093.40
Gains per Year (598 shares)378.81373.61
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
17830136960313364
2155603748121626738
323390411271819391112
43101205150624212531486
53881507188530215661860
64651808226436318792234
75432109264342321922608
86202410302248425052982
96982712340154428183356
107753013378060531313730

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.02.080.0%8.00.04.066.7%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%

Fundamentals of Ningbo Menovo Pharm Co Ltd

About Ningbo Menovo Pharm Co Ltd

Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. The company's products portfolio includes valsartan, losartan, clopidogrel, perindopril, rosuvastatin calcium, atorvastatin calcium, purin bahrain, and other products. It offers APIs, intermediates, and preparations for the treatment of cardiovascular, central nervous system, gastrointestinal tract, and other therapeutic areas. Ningbo Menovo Pharmaceutical Co., Ltd. was founded in 2004 and is headquartered in Ningbo, China.

Fundamental data was last updated by Penke on 2024-03-27 22:52:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Ningbo Menovo Pharm Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ningbo Menovo Pharm Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Ningbo Menovo Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 23.2% means that ¥0.23 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ningbo Menovo Pharm Co Ltd:

  • The MRQ is 23.2%. The company is making a huge profit. +2
  • The TTM is 23.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ23.2%TTM23.2%0.0%
TTM23.2%YOY11.3%+11.9%
TTM23.2%5Y14.5%+8.7%
5Y14.5%10Y9.4%+5.2%
1.1.2. Return on Assets

Shows how efficient Ningbo Menovo Pharm Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ningbo Menovo Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 7.7% Return on Assets means that Ningbo Menovo Pharm Co Ltd generated ¥0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ningbo Menovo Pharm Co Ltd:

  • The MRQ is 7.7%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 7.7%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ7.7%TTM7.7%0.0%
TTM7.7%YOY3.6%+4.1%
TTM7.7%5Y5.3%+2.3%
5Y5.3%10Y3.8%+1.6%
1.1.3. Return on Equity

Shows how efficient Ningbo Menovo Pharm Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ningbo Menovo Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 16.2% Return on Equity means Ningbo Menovo Pharm Co Ltd generated ¥0.16 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ningbo Menovo Pharm Co Ltd:

  • The MRQ is 16.2%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 16.2%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ16.2%TTM16.2%0.0%
TTM16.2%YOY8.1%+8.1%
TTM16.2%5Y10.9%+5.4%
5Y10.9%10Y7.0%+3.9%

1.2. Operating Efficiency of Ningbo Menovo Pharm Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ningbo Menovo Pharm Co Ltd is operating .

  • Measures how much profit Ningbo Menovo Pharm Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ningbo Menovo Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ningbo Menovo Pharm Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY13.5%-13.5%
TTM-5Y10.6%-10.6%
5Y10.6%10Y8.9%+1.8%
1.2.2. Operating Ratio

Measures how efficient Ningbo Menovo Pharm Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.43 means that the operating costs are ¥1.43 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Ningbo Menovo Pharm Co Ltd:

  • The MRQ is 1.432. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.432. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.432TTM1.4320.000
TTM1.432YOY1.477-0.045
TTM1.4325Y1.472-0.040
5Y1.47210Y1.227+0.245

1.3. Liquidity of Ningbo Menovo Pharm Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ningbo Menovo Pharm Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.39 means the company has ¥1.39 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Ningbo Menovo Pharm Co Ltd:

  • The MRQ is 1.391. The company is just able to pay all its short-term debts.
  • The TTM is 1.391. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.391TTM1.3910.000
TTM1.391YOY1.484-0.094
TTM1.3915Y1.315+0.076
5Y1.31510Y1.048+0.267
1.3.2. Quick Ratio

Measures if Ningbo Menovo Pharm Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ningbo Menovo Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.28 means the company can pay off ¥0.28 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ningbo Menovo Pharm Co Ltd:

  • The MRQ is 0.284. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.284. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.284TTM0.2840.000
TTM0.284YOY0.507-0.224
TTM0.2845Y0.326-0.042
5Y0.32610Y0.370-0.044

1.4. Solvency of Ningbo Menovo Pharm Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ningbo Menovo Pharm Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ningbo Menovo Pharm Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.51 means that Ningbo Menovo Pharm Co Ltd assets are financed with 50.8% credit (debt) and the remaining percentage (100% - 50.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ningbo Menovo Pharm Co Ltd:

  • The MRQ is 0.508. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.508. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.508TTM0.5080.000
TTM0.508YOY0.506+0.003
TTM0.5085Y0.450+0.059
5Y0.45010Y0.379+0.071
1.4.2. Debt to Equity Ratio

Measures if Ningbo Menovo Pharm Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ningbo Menovo Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 107.7% means that company has ¥1.08 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ningbo Menovo Pharm Co Ltd:

  • The MRQ is 1.077. The company is able to pay all its debts with equity. +1
  • The TTM is 1.077. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.077TTM1.0770.000
TTM1.077YOY1.155-0.078
TTM1.0775Y0.923+0.154
5Y0.92310Y0.712+0.211

2. Market Valuation of Ningbo Menovo Pharm Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Ningbo Menovo Pharm Co Ltd generates.

  • Above 15 is considered overpriced but always compare Ningbo Menovo Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 16.22 means the investor is paying ¥16.22 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ningbo Menovo Pharm Co Ltd:

  • The EOD is 7.622. Based on the earnings, the company is underpriced. +1
  • The MRQ is 16.220. Based on the earnings, the company is fair priced.
  • The TTM is 16.220. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD7.622MRQ16.220-8.598
MRQ16.220TTM16.2200.000
TTM16.220YOY53.156-36.936
TTM16.2205Y39.735-23.515
5Y39.73510Y32.470+7.265
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ningbo Menovo Pharm Co Ltd:

  • The EOD is -8.762. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -18.646. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -18.646. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.762MRQ-18.646+9.884
MRQ-18.646TTM-18.6460.000
TTM-18.646YOY-24.497+5.851
TTM-18.6465Y-45.402+26.755
5Y-45.40210Y-115.554+70.152
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ningbo Menovo Pharm Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Ningbo Menovo Pharm Co Ltd:

  • The EOD is 1.188. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.528. Based on the equity, the company is underpriced. +1
  • The TTM is 2.528. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.188MRQ2.528-1.340
MRQ2.528TTM2.5280.000
TTM2.528YOY3.829-1.301
TTM2.5285Y3.469-0.941
5Y3.46910Y2.219+1.250
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Ningbo Menovo Pharm Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.9110.9110%1.013-10%0.947-4%0.811+12%
Book Value Per Share--10.18510.1850%9.273+10%8.271+23%5.818+75%
Current Ratio--1.3911.3910%1.484-6%1.315+6%1.048+33%
Debt To Asset Ratio--0.5080.5080%0.506+1%0.450+13%0.379+34%
Debt To Equity Ratio--1.0771.0770%1.155-7%0.923+17%0.712+51%
Dividend Per Share--0.2340.2340%0.065+262%0.183+28%0.113+107%
Eps--1.5881.5880%0.668+138%0.829+91%0.509+212%
Free Cash Flow Per Share---1.381-1.3810%-1.450+5%-0.999-28%-0.416-70%
Free Cash Flow To Equity Per Share---1.381-1.3810%1.284-208%0.157-980%0.398-447%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.700+43%
Intrinsic Value_10Y_max---8.827--------
Intrinsic Value_10Y_min---17.634--------
Intrinsic Value_1Y_max---0.518--------
Intrinsic Value_1Y_min---1.234--------
Intrinsic Value_3Y_max---1.837--------
Intrinsic Value_3Y_min---4.191--------
Intrinsic Value_5Y_max---3.491--------
Intrinsic Value_5Y_min---7.656--------
Market Cap2581547196.800-113%5494478659.0005494478659.0000%7576094294.080-27%6092162723.032-10%3609114671.628+52%
Net Profit Margin--0.2320.2320%0.113+105%0.145+60%0.094+148%
Operating Margin----0%0.135-100%0.106-100%0.089-100%
Operating Ratio--1.4321.4320%1.477-3%1.472-3%1.227+17%
Pb Ratio1.188-113%2.5282.5280%3.829-34%3.469-27%2.219+14%
Pe Ratio7.622-113%16.22016.2200%53.156-69%39.735-59%32.470-50%
Price Per Share12.100-113%25.75025.7500%35.510-27%28.554-10%16.916+52%
Price To Free Cash Flow Ratio-8.762+53%-18.646-18.6460%-24.497+31%-45.402+143%-115.554+520%
Price To Total Gains Ratio10.559-113%22.47122.4710%32.960-32%25.466-12%23.375-4%
Quick Ratio--0.2840.2840%0.507-44%0.326-13%0.370-23%
Return On Assets--0.0770.0770%0.036+115%0.053+43%0.038+102%
Return On Equity--0.1620.1620%0.081+100%0.109+50%0.070+133%
Total Gains Per Share--1.1461.1460%1.077+6%1.130+1%0.924+24%
Usd Book Value--300341793.660300341793.6600%273429432.677+10%243865192.600+23%171562078.406+75%
Usd Book Value Change Per Share--0.1260.1260%0.140-10%0.131-4%0.112+12%
Usd Book Value Per Share--1.4081.4080%1.282+10%1.143+23%0.804+75%
Usd Dividend Per Share--0.0320.0320%0.009+262%0.025+28%0.016+107%
Usd Eps--0.2190.2190%0.092+138%0.115+91%0.070+212%
Usd Free Cash Flow---40722872.325-40722872.3250%-42740243.712+5%-29446809.121-28%-12276666.439-70%
Usd Free Cash Flow Per Share---0.191-0.1910%-0.200+5%-0.138-28%-0.058-70%
Usd Free Cash Flow To Equity Per Share---0.191-0.1910%0.177-208%0.022-980%0.055-447%
Usd Market Cap356769822.598-113%759336950.674759336950.6740%1047016231.442-27%841936888.323-10%498779647.619+52%
Usd Price Per Share1.672-113%3.5593.5590%4.907-27%3.946-10%2.338+52%
Usd Profit--46814592.57346814592.5730%19697143.783+138%24762553.022+89%14088334.472+232%
Usd Revenue--201354973.516201354973.5160%173876013.545+16%164126179.434+23%122207293.383+65%
Usd Total Gains Per Share--0.1580.1580%0.149+6%0.156+1%0.128+24%
 EOD+3 -5MRQTTM+0 -0YOY+22 -135Y+19 -1610Y+22 -14

3.2. Fundamental Score

Let's check the fundamental score of Ningbo Menovo Pharm Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-157.622
Price to Book Ratio (EOD)Between0-11.188
Net Profit Margin (MRQ)Greater than00.232
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.284
Current Ratio (MRQ)Greater than11.391
Debt to Asset Ratio (MRQ)Less than10.508
Debt to Equity Ratio (MRQ)Less than11.077
Return on Equity (MRQ)Greater than0.150.162
Return on Assets (MRQ)Greater than0.050.077
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Ningbo Menovo Pharm Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.639
Ma 20Greater thanMa 5013.998
Ma 50Greater thanMa 10013.553
Ma 100Greater thanMa 20016.275
OpenGreater thanClose12.650
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets4,419,458
Total Liabilities2,246,218
Total Stockholder Equity2,084,987
 As reported
Total Liabilities 2,246,218
Total Stockholder Equity+ 2,084,987
Total Assets = 4,419,458

Assets

Total Assets4,419,458
Total Current Assets1,894,382
Long-term Assets2,525,076
Total Current Assets
Cash And Cash Equivalents 791,943
Short-term Investments 217,378
Net Receivables 168,845
Inventory 594,415
Other Current Assets 74,610
Total Current Assets  (as reported)1,894,382
Total Current Assets  (calculated)1,847,191
+/- 47,191
Long-term Assets
Property Plant Equipment 1,801,928
Intangible Assets 172,493
Other Assets 280,307
Long-term Assets  (as reported)2,525,076
Long-term Assets  (calculated)2,254,729
+/- 270,347

Liabilities & Shareholders' Equity

Total Current Liabilities1,362,219
Long-term Liabilities883,999
Total Stockholder Equity2,084,987
Total Current Liabilities
Short Long Term Debt 465,281
Accounts payable 345,446
Other Current Liabilities 463,780
Total Current Liabilities  (as reported)1,362,219
Total Current Liabilities  (calculated)1,274,507
+/- 87,713
Long-term Liabilities
Long term Debt 675,253
Capital Lease Obligations Min Short Term Debt30,344
Deferred Long Term Liability 50,157
Long-term Liabilities  (as reported)883,999
Long-term Liabilities  (calculated)755,754
+/- 128,245
Total Stockholder Equity
Retained Earnings 1,234,320
Total Stockholder Equity (as reported)2,084,987
Total Stockholder Equity (calculated)1,234,320
+/- 850,668
Other
Capital Stock213,378
Common Stock Shares Outstanding 213,378
Net Debt 348,590
Net Invested Capital 3,225,521
Net Tangible Assets 1,942,260
Net Working Capital 532,163
Property Plant and Equipment Gross 1,801,928



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
709,967
831,581
864,686
966,885
827,644
955,292
1,513,706
2,271,082
2,613,970
3,062,723
4,001,495
4,419,458
4,419,4584,001,4953,062,7232,613,9702,271,0821,513,706955,292827,644966,885864,686831,581709,967
   > Total Current Assets 
0
0
0
0
0
346,719
777,339
1,073,130
1,136,397
1,185,827
1,702,398
1,894,382
1,894,3821,702,3981,185,8271,136,3971,073,130777,339346,71900000
       Cash And Cash Equivalents 
128,496
63,739
119,469
185,052
99,550
125,161
258,552
369,950
342,258
235,669
421,787
791,943
791,943421,787235,669342,258369,950258,552125,16199,550185,052119,46963,739128,496
       Short-term Investments 
3,375
351
0
0
0
0
252,000
0
100,599
133,143
371,377
217,378
217,378371,377133,143100,5990252,00000003513,375
       Net Receivables 
61,602
137,923
53,396
167,765
37,338
64,266
87,653
191,641
198,051
158,908
210,192
168,845
168,845210,192158,908198,051191,64187,65364,26637,338167,76553,396137,92361,602
       Other Current Assets 
7,020
12,000
9,212
11,726
13,762
13,820
32,379
212,538
65,315
79,858
90,288
74,610
74,61090,28879,85865,315212,53832,37913,82013,76211,7269,21212,0007,020
   > Long-term Assets 
0
0
0
0
0
608,572
736,367
1,197,952
1,477,572
1,928,621
2,299,098
2,525,076
2,525,0762,299,0981,928,6211,477,5721,197,952736,367608,57200000
       Property Plant Equipment 
275,390
343,788
397,595
259,559
260,398
290,215
358,736
738,765
927,366
1,144,988
1,614,682
1,801,928
1,801,9281,614,6821,144,988927,366738,765358,736290,215260,398259,559397,595343,788275,390
       Goodwill 
0
0
0
0
0
0
0
51,002
51,002
22,741
22,741
0
022,74122,74151,00251,0020000000
       Intangible Assets 
95,661
95,189
93,292
51,105
65,325
108,615
107,456
175,419
183,245
224,671
201,698
172,493
172,493201,698224,671183,245175,419107,456108,61565,32551,10593,29295,18995,661
       Long-term Assets Other 
0
0
0
0
0
16,526
9,115
47,369
97,243
61,983
63,920
51,203
51,20363,92061,98397,24347,3699,11516,52600000
> Total Liabilities 
331,497
389,005
377,243
402,545
181,831
224,268
351,191
930,920
1,045,450
1,300,241
2,022,990
2,246,218
2,246,2182,022,9901,300,2411,045,450930,920351,191224,268181,831402,545377,243389,005331,497
   > Total Current Liabilities 
330,286
388,567
376,893
398,146
176,758
213,599
340,142
779,437
876,398
1,155,331
1,146,820
1,362,219
1,362,2191,146,8201,155,331876,398779,437340,142213,599176,758398,146376,893388,567330,286
       Short-term Debt 
0
0
0
0
0
67,000
155,029
427,949
429,443
0
0
0
000429,443427,949155,02967,00000000
       Short Long Term Debt 
0
0
0
0
0
67,000
155,029
427,949
429,443
602,150
425,867
465,281
465,281425,867602,150429,443427,949155,02967,00000000
       Accounts payable 
132,698
143,314
156,509
206,314
118,409
118,049
154,667
262,454
308,937
372,059
389,053
345,446
345,446389,053372,059308,937262,454154,667118,049118,409206,314156,509143,314132,698
       Other Current Liabilities 
64,628
42,883
55,734
32,832
28,348
8,205
6,814
50,570
50,049
46,290
202,116
463,780
463,780202,11646,29050,04950,5706,8148,20528,34832,83255,73442,88364,628
   > Long-term Liabilities 
0
0
0
0
0
10,669
11,049
151,483
169,052
187,899
876,170
883,999
883,999876,170187,899169,052151,48311,04910,66900000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
-67,000
-155,029
-427,949
-429,443
26,844
28,030
30,344
30,34428,03026,844-429,443-427,949-155,029-67,00000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
107,906
123,440
0
0
0
000123,440107,9060000000
       Deferred Long Term Liability 
0
0
0
0
9,320
13,261
6,980
16,400
20,830
33,168
41,087
50,157
50,15741,08733,16820,83016,4006,98013,2619,3200000
> Total Stockholder Equity
362,204
423,734
463,942
535,043
611,155
690,077
1,116,293
1,197,154
1,364,142
1,551,721
1,751,484
2,084,987
2,084,9871,751,4841,551,7211,364,1421,197,1541,116,293690,077611,155535,043463,942423,734362,204
   Common Stock
90,000
90,000
90,000
90,000
90,000
90,000
120,000
149,134
149,682
149,609
151,317
0
0151,317149,609149,682149,134120,00090,00090,00090,00090,00090,00090,000
   Retained Earnings 
133,434
161,789
216,651
289,505
366,338
445,181
489,859
564,608
685,702
819,604
962,131
1,234,320
1,234,320962,131819,604685,702564,608489,859445,181366,338289,505216,651161,789133,434
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
0
0
0
0
-696
-618
-529
2,728
4,291
4,233
78,796
0
078,7964,2334,2912,728-529-618-6960000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,154,827
Cost of Revenue-771,831
Gross Profit382,995382,995
 
Operating Income (+$)
Gross Profit382,995
Operating Expense-1,095,923
Operating Income58,904-712,928
 
Operating Expense (+$)
Research Development91,470
Selling General Administrative119,959
Selling And Marketing Expenses-
Operating Expense1,095,923211,429
 
Net Interest Income (+$)
Interest Income2,379
Interest Expense-28,523
Other Finance Cost-7,328
Net Interest Income-33,473
 
Pretax Income (+$)
Operating Income58,904
Net Interest Income-33,473
Other Non-Operating Income Expenses-
Income Before Tax (EBT)172,28858,904
EBIT - interestExpense = -28,523
179,285
207,808
Interest Expense28,523
Earnings Before Interest and Taxes (EBIT)-200,811
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax172,288
Tax Provision--20,446
Net Income From Continuing Ops192,734192,734
Net Income179,285
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-33,473
 

Technical Analysis of Ningbo Menovo Pharm Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ningbo Menovo Pharm Co Ltd. The general trend of Ningbo Menovo Pharm Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ningbo Menovo Pharm Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ningbo Menovo Pharm Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 12.81 < 15.29 < 16.18.

The bearish price targets are: 9.96.

Tweet this
Ningbo Menovo Pharm Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ningbo Menovo Pharm Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ningbo Menovo Pharm Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ningbo Menovo Pharm Co Ltd. The current macd is -0.28200304.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ningbo Menovo Pharm Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Ningbo Menovo Pharm Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Ningbo Menovo Pharm Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Ningbo Menovo Pharm Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartNingbo Menovo Pharm Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ningbo Menovo Pharm Co Ltd. The current adx is 16.21.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Ningbo Menovo Pharm Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Ningbo Menovo Pharm Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ningbo Menovo Pharm Co Ltd. The current sar is 14.82.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Ningbo Menovo Pharm Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ningbo Menovo Pharm Co Ltd. The current rsi is 32.64. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Ningbo Menovo Pharm Co Ltd Daily Relative Strength Index (RSI) ChartNingbo Menovo Pharm Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ningbo Menovo Pharm Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ningbo Menovo Pharm Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Ningbo Menovo Pharm Co Ltd Daily Stochastic Oscillator ChartNingbo Menovo Pharm Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ningbo Menovo Pharm Co Ltd. The current cci is -268.97358084.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Ningbo Menovo Pharm Co Ltd Daily Commodity Channel Index (CCI) ChartNingbo Menovo Pharm Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ningbo Menovo Pharm Co Ltd. The current cmo is -47.95377642.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Ningbo Menovo Pharm Co Ltd Daily Chande Momentum Oscillator (CMO) ChartNingbo Menovo Pharm Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ningbo Menovo Pharm Co Ltd. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Ningbo Menovo Pharm Co Ltd Daily Williams %R ChartNingbo Menovo Pharm Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ningbo Menovo Pharm Co Ltd.

Ningbo Menovo Pharm Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ningbo Menovo Pharm Co Ltd. The current atr is 0.61892032.

Ningbo Menovo Pharm Co Ltd Daily Average True Range (ATR) ChartNingbo Menovo Pharm Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ningbo Menovo Pharm Co Ltd. The current obv is 122,923,603.

Ningbo Menovo Pharm Co Ltd Daily On-Balance Volume (OBV) ChartNingbo Menovo Pharm Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ningbo Menovo Pharm Co Ltd. The current mfi is 28.41.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Ningbo Menovo Pharm Co Ltd Daily Money Flow Index (MFI) ChartNingbo Menovo Pharm Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ningbo Menovo Pharm Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Ningbo Menovo Pharm Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ningbo Menovo Pharm Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.639
Ma 20Greater thanMa 5013.998
Ma 50Greater thanMa 10013.553
Ma 100Greater thanMa 20016.275
OpenGreater thanClose12.650
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ningbo Menovo Pharm Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Ningbo Menovo Pharm Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ningbo Menovo Pharm Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ningbo Menovo Pharm Co Ltd

I send you an email if I find something interesting about Ningbo Menovo Pharm Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Ningbo Menovo Pharm Co Ltd.

Receive notifications about Ningbo Menovo Pharm Co Ltd in your mailbox!